APF
AGN

Alaska Permanent Fund’s Allergan plc AGN Stock Holding History

Alaska Permanent Fund’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,470
Closed -$969K – 241
2020
Q1 		$969K Buy
+5,470
New +$1.03M 0.02% 44

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Alaska Permanent Fund's AGN Position: Q2 2020 in Review

Alaska Permanent Fund sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,470 shares — an estimated $969K sold.

Alaska Permanent Fund first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $969K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Alaska Permanent Fund reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Alaska Permanent Fund sold 5,470 Allergan plc shares in Q2 2020, an estimated $969K.
  • Alaska Permanent Fund first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • Alaska Permanent Fund's Allergan plc position peaked at $969K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Alaska Permanent Fund's 13F filing for Q2 2020, filed 12 Aug 2020.